skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
04/12/2022
Application #:
16758986
Filing Dt:
04/24/2020
Publication #:
Pub Dt:
11/05/2020
Inventors:
Mitchell J. Weiss, Christophe Lechauve, Mondira Kundu
Title:
METHOD FOR TREATING THALASSEMIA
Assignment: 1
Reel/Frame:
052487/0676Recorded: 04/24/2020Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
11/03/2017
Exec Dt:
11/03/2017
Exec Dt:
11/07/2017
Assignee:
262 DANNY THOMAS PLACE
MEMPHIS, TENNESSEE 38105
Correspondent:
JANE MASSEY LICATA
LICATA & TYRRELL P.C.
66 E. MAIN ST.
MARLTON, NJ 08053
Assignment: 2
Reel/Frame:
053465/0877Recorded: 08/12/2020Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
08/10/2020
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980
Assignment: 3
Reel/Frame:
053466/0253Recorded: 08/12/2020Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
08/10/2020
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 05/08/2024 05:56 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT